MEDIFAST INC MED
MEDIFAST INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
MEDIFAST INC trades at about 61× earnings — above its 10-year norm (10-year range 6×–82.6×, median 27×).
Shaded band = 10-year range (6×–82.6×); dot = today's 61×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 71.3% | 73.8% | 72.4% | 71.3% | 73.9% | 74.6% | 75.2% | 75.8% | 75.5% | 74.9% |
| Operating margin | -3.7% | 0.5% | 11.8% | 11.6% | 14.2% | 14.4% | 12.8% | 13.8% | 13.1% | 9.8% |
| Net margin | -4.8% | 0.3% | 9.3% | 9.0% | 10.7% | 11.0% | 10.9% | 11.1% | 9.2% | 6.5% |
| FCF margin | 0.3% | 2.8% | 13.2% | 11.1% | 4.0% | 14.9% | 10.4% | 11.2% | 13.3% | 8.4% |
| Return on assets | -7.5% | 0.7% | 32.1% | 45.4% | 41.2% | 37.3% | 40.0% | 32.9% | 19.0% | 14.7% |
| Return on equity | -9.4% | 1.0% | 49.3% | 92.6% | 81.0% | 65.4% | 74.3% | 51.1% | 26.0% | 18.6% |
| Current ratio | 4.69 | 3.34 | 2.43 | 1.58 | 1.81 | 2.10 | 1.94 | 2.41 | 3.37 | 4.15 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.